Trial Profile
ECG changes and C-protein level variations during and after treatment with atorvastatin at different dosages in the secondary prevention of stroke.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 04 Jun 2014
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 04 Jun 2014 New trial record